Reduced blood flow in normal white matter predicts development of leukoaraiosis

Journal of Cerebral Blood Flow and Metabolism

Volumn 35, Issue 10, 2015, Pages 1610-1615

  Bernbaum, Manya ^a,b   Menon, Bijoy K ^a,b,c   Fick, Gordon ^c   Smith, Eric E ^a,b,c   Goyal, Mayank ^a,b,c   Frayne, Richard ^a,b,c   Coutts, Shelagh B ^a,b,c  

^a FOOTHILLS HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

cerebral blood flow; leukoaraiosis; white matter hyperintensities

Indexed keywords

GADOBUTROL; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; LEUKOARAIOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; WHITE MATTER; AGED; BRAIN CIRCULATION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASE COURSE; PATHOLOGY; STATISTICAL MODEL; TRANSIENT ISCHEMIC ATTACK; VASCULARIZATION;

AGED; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DIABETES COMPLICATIONS; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISCHEMIC ATTACK, TRANSIENT; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, STATISTICAL; STROKE; WHITE MATTER;

EID: 84942980929     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.92     Document Type: Article

References (35)

1. Smith EE. Leukoaraiosis and stroke. Stroke 2010; 41: S139-S143.
2. Vermeer SE, Hollander M, Van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003; 34: 1126-1129.
3. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-1222.
4. Kuller LH, Longstreth WT, Jr., Arnold AM, Bernick C, Bryan RN, Beauchamp NJ, Jr. et al. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004; 35: 1821-1825.
5. Maillard P, Carmichael O, Harvey D, Fletcher E, Reed B, Mungas D et al. FLAIR and diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR Am J Neuroradiol 2013; 34: 54-61.
6. De Groot M, Verhaaren BF, De Boer R, Klein S, Hofman A, Van Der Lugt A et al. Changes in normal-Appearing white matter precede development of white matter lesions. Stroke 2013; 44: 1037-1042.
7. Yao H, Sadoshima S, Kuwabara Y, Ichiya Y, Fujishima M. Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke 1990; 21: 1694-1699.
8. O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002; 59: 321-326.
9. Coutts SB, Modi J, Patel SK, Demchuk AM, Goyal M, Hill MD et al. CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke 2012; 43: 1013-1017.
10. Wu O, Ostergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003; 50: 164-174.
11. Kane I, Carpenter T, Chappell F, Rivers C, Armitage P, Sandercock P et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 2007; 38: 3158-3164.
12. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-838.
13. Oishi M, Mochizuki Y, Hara M, Takasu T. Central motor conduction time in patients with periventricular lucencies. J Neurol Sci 1996; 142: 30-35.
14. Miyazawa N, Satoh T, Hashizume K, Fukamachi A. Xenon contrast CT-CBF measurements in high-intensity foci on T2-weighted MR images in centrum semiovale of asymptomatic individuals. Stroke 1997; 28: 984-987.
15. Yao H, Sadoshima S, Ibayashi S, Kuwabara Y, Ichiya Y, Fujishima M. Leukoaraiosis and dementia in hypertensive patients. Stroke 1992; 23: 1673-1677.
16. Hatazawa J, Shimosegawa E, Satoh T, Toyoshima H, Okudera T. Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging. Stroke 1997; 28: 1944-1947.
17. Matsusue E, Sugihara S, Fujii S, Ohama E, Kinoshita T, Ogawa T. White matter changes in elderly people: MR-pathologic correlations. Magn Reson Med Sci 2006; 5: 99-104.
18. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683-1689.
19. Van Swieten JC, Van den Hout JH, Van Ketel BA, Hijdra A, Wokke JH, Van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991; 114: 761-774.
20. O'Sullivan M. Leukoaraiosis. Pract Neurol 2008; 8: 26-38.
21. O'Sullivan M, Summers PE, Jones DK, Jarosz JM, Williams SC, Markus HS. Normalappearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001; 57: 2307-2310.
22. Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126: 424-432.
23. Korf ES, Van Straaten EC, De Leeuw FE, Van Der Flier WM, Barkhof F, Pantoni L et al. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med 2007; 24: 166-171.
24. Van Harten B, Oosterman JM, Potter Van Loon BJ, Scheltens P, Weinstein HC. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 2007; 57: 70-74.
25. Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 2006; 67: 1960-1965.
26. Longstreth WT, Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274-1282.
27. Schmidt R, Launer LJ, Nilsson LG, Pajak A, Sans S, Berger K et al. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 2004; 53: 687-692.
28. Sachdev PS, Wen W, Christensen H, Jorm AF. White matter hyperintensities are related to physical disability and poor motor function. J Neurol Neurosurg Psychiatry 2005; 76: 362-367.
29. De Leeuw FE, De Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70: 9-14.
30. Breteler MM, Van Swieten JC, Bots ML, Grobbee DE, Claus JJ, Van den Hout JH et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994; 44: 1246-1252.
31. Burns A, Murphy D. Protection against Alzheimer's disease?. Lancet 1996; 348: 420-421.
32. Goodman Y, Bruce AJ, Cheng B, Mattson MP. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 1996; 66: 1836-1844.
33. McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997; 48: S8-15.
34. Godin O, Tzourio C, Maillard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation 2011; 123: 266-273.
35. Menon BK, Smith EE, Coutts SB, Welsh DG, Faber JE, Goyal M et al. Leptomeningeal collaterals are associated with modifiable metabolic risk factors. Ann Neurol 2013; 74: 241-248.